MAPK7 and cancer: Numerous studies indicate that the ERK5 signaling pathway contributes to epithelial–mesenchymal transition, invasion, and metastasis across different cancers through varied mechanisms, with microRNA and knockdown strategies capable of inhibiting these processes [148].